Etofamide
Systematic (IUPAC) name | |
---|---|
2,2-dichloro-N-(2-ethoxyethyl)-N- [4-(4-nitrophenoxy)benzyl]acetamide | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
Legal status |
|
Identifiers | |
CAS Number | 25287-60-9 |
ATC code | P01AC03 (WHO) |
PubChem | CID 65718 |
ChemSpider | 59142 |
UNII | 03F36JH21U |
KEGG | D07355 |
ChEMBL | CHEMBL1788393 |
Chemical data | |
Formula | C19H20Cl2N2O5 |
Molar mass | 427.27 g/mol |
| |
| |
(verify) |
Etofamide (INN, also known as eticlordifene) is an antiprotozoal drug used in the treatment of amoebiasis.
Its effect against Giardia lamblia has been described as modest.[1]
References
- ↑ Cedillo-Rivera R, Muñoz O (September 1992). "In-vitro susceptibility of Giardia lamblia to albendazole, mebendazole and other chemotherapeutic agents". J. Med. Microbiol. 37 (3): 221–4. doi:10.1099/00222615-37-3-221. PMID 1518040.
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.